이영은 (한국과학기술연구원, 고려대학교)님 | 한빛사연구자 > 한빛사

한국과학기술연구원, 고려대학교

최종업데이트 2024.10.15.

An innovative strategy harnessing self-activating CAR-NK cells to mitigate TGF-β1-driven immune suppression
- Biomaterials, Available online 10 October 2024, 122888 | https://doi.org/10.1016/j.biomaterials.2024.122888
- 2024-10
- 바이오·의료융합
- 한빛사논문
Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK- mediated cytotoxicity via reduction of CAF-released IL-6
- J. Immunother. Cancer, 2023 Feb;11(2):e006130 | https://jitc.bmj.com/content/11/2/e006130
- 2023-02
- 생명과학
- 한빛사논문
A Novel Therapeutic Modality using CRISPR-Engineered Dendritic Cells to Treat Allergies
- Biomaterials, Available online 10 April 2021, 120798 | https://doi.org/10.1016/j.biomaterials.2021.120798
- 2021-04
- 의약학
- 한빛사논문

연구자 ID

저자논문